Tag: moderna

We know exactly how and why the DNA is in the Moderna and Pfizer vials

This past week has been epic for me. Not only did I have the extreme pleasure of volunteering alongside Kevin McKernan and Charles Rixey at Medicinal Genomics, but we have pretty much confirmed how the DNA is in the Moderna and Pfizer COVID shot vials.

Ages ago, when I was presenting the original findings that there was DNA in these vials, I was sleuthing how this happened by looking into the N1-methylpseudouridine modified RNA synthesis pathway as part of Process 2 manufacturing. Process 2 involved using a plasmid/E. coli system, don’t forget. And also don’t forget that this methodology was bait ‘n’ switched and was not safety tested.

N1-methylpseudouridine has a higher melting temperature than Uridine.1 (Higher thermal energy or specific enzymatic activity is required to disrupt base pairing.) What this means in terms of it binding a cognate base is that it will require a very high temperature to rip them apart. Either that, or it will require a specific enzyme. Two examples of such specific enzymes are RNase-H (in us) and RNase-XT (on bench). It is well-known in nerdy science circles that DNase1 – the enzyme the COVID shot manufacturers used to chop up the DNA for endpoint synthesis cleaning – does not work on DNA:RNA hybrids.

Keep reading

Moderna’s COVID Shot Plasmid Contains Human Blood Gene Fragment Capable of Integrating Into DNA—Same System Dominating Post-Vaccine Injuries

Moderna’s COVID-19 vaccine plasmid contains a human α-globin DNA fragment regulating blood and cardiovascular biology, and because plasmids are integration-competent DNA molecules, this fragment is capable of inserting into the human genome—precisely as blood and cardiovascular injuries like myocarditis and pericarditis emerge as the dominant serious adverse events following Moderna vaccination.

In plain terms, Moderna’s shot carries a piece of human blood gene code that can lodge itself into patient DNA, raising the possibility that the very blueprint of the vaccine is fueling the same heart and blood injuries now seen at the top of its safety reports.

While most public discussion blames the spike protein or lipid nanoparticles for Moderna’s adverse events, the evidence here points to something no one is talking about—the plasmid blueprint itself may be driving the blood and heart injuries dominating the safety signal.

A September 2025 peer-reviewed paper in Molecular Therapy: Nucleic Acids confirms that Moderna’s mRNA-1273 (Spikevax) vaccine plasmid carries a 3’ untranslated region (UTR) from the human α-globin (HBA1) gene.

  • α-globin encodes part of hemoglobin, central to red blood cell stability and oxygen transport.
  • Its regulation is directly tied to blood and cardiovascular function—mutations cause α-thalassemia, anemia, and cardiac stress.
  • By design, Moderna’s blueprint hard-codes this human blood gene regulator into the plasmid template.

Keep reading

Moderna To Ask For Clearance For Combination COVID-Influenza Vaccine

Moderna is going to ask regulators to approve its combination vaccine against COVID-19 and influenza, the company said on June 30.

The company said a phase 3 study evaluating its influenza vaccine candidate, mRNA-1010—which utilizes the same messenger ribonucleic acid (mRNA) platform as its COVID-19 vaccine—showed positive effectiveness.

In the trial, which featured 40,805 participants and compared mRNA-1010 to an existing seasonal flu vaccine in adults aged 50 and up, the relative protection from the candidate was 26.6 percent better. In a subgroup analysis among participants aged at least 65, the relative efficacy was 27.4 percent.

“Today’s strong Phase 3 efficacy results are a significant milestone in our effort to reduce the burden of influenza in older adults,” Stéphane Bancel, Moderna’s CEO, said in a statement.

Several companies, including Moderna, have been planning to introduce combination shots against COVID-19 and influenza.

Moderna, however, in May withdrew its application for approval for its combination vaccine, a move the company said came after consulting with the Food and Drug Administration.

Moderna at the time said it planned to resubmit the application before the end of 2025 after it received efficacy data from the phase 3 trial for mRNA 1010.

“An mRNA-based flu vaccine has the potential advantage to more precisely match circulating strains, support rapid response in a future influenza pandemic, and pave the way for COVID-19 combination vaccines,” Bancel said on Monday.

The trial results have been fully published or peer reviewed. Moderna said it plans to submit the results to a peer-reviewed journal.

Keep reading

FDA approves Moderna’s new lower-dose COVID-19 vaccine

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company’s existing shot, but a second option.

The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It’s made in a way that allows for a lower dose — a fifth of the dose of its current COVID-19 vaccine, Spikevax — by refining its immune target.

The approval “adds an important new tool to help protect people at high risk of severe disease from COVID-19,” Stephane Bancel, Moderna’s CEO, said in a statement Saturday.

The Food and Drug Administration approved the new vaccine for use in all adults 65 and older, and for people age 12 to 64 who have a least one health condition that puts them at increased risk from the coronavirus.

That’s the same limit that the FDA set in licensing another COVID-19 vaccine option from competitor Novavax.

Those restrictions are a departure from how the U.S. has handled COVID-19 vaccines until now, reflecting skepticism about vaccines from Health Secretary Robert F. Kennedy Jr. and other Trump officials.

Moderna’s existing vaccine doesn’t face those limits and has long been used for anyone ages 6 months and older. The company said it expected to offer both options this fall.

Keep reading

Moderna Pulls Application for FDA Approval of Flu-COVID Shot After FDA Calls for New Clinical Trials

Moderna is withdrawing its application for U.S. Food and Drug Administration (FDA) approval of its mRNA-1083 combination flu and COVID-19 vaccine, the company announced today — just one day after the FDA said it would require new clinical trials to approve COVID-19 boosters for healthy people under 65.

According to Fierce Biotech, the company will resubmit its application when data from a Phase 3 trial of its mRNA-1010 flu vaccine, which is a component of the combined shot, are available later this year. The company expects to have interim data from the trial available this summer.

Markets reacted negatively to the news, with Moderna’s shares falling 1.4% in premarket trading on Wednesday, The Guardian reported.

According to Reuters, Moderna’s decision to withdraw its application at this time “is the latest sign of increased regulatory scrutiny of the vaccine approval process since Robert F. Kennedy Jr. took the top U.S. health job earlier this year.”

Last week, for instance, the FDA approved Novavax’s new COVID-19 vaccine, but limited its approval to groups that are considered high-risk.

Sayer Ji, co-founder of Stand for Health Freedom and founder and director of GreenMedInfo, said Moderna’s decision to withdraw its application is “telling” and “appears to reflect not only concerns over efficacy but also a growing public skepticism toward hastily developed, multi-antigen formulations that lack sufficient long-term safety data.”

Ji said:

“The withdrawal may be a preemptive move to avoid public scrutiny or regulatory resistance tied to unresolved questions in their clinical data. Combination shots, especially those involving mRNA platforms, introduce compounded risks due to the simultaneous delivery of multiple immunogenic agents.

“These risks are poorly understood and grossly under-evaluated, particularly in vulnerable populations. The immunological complexity of such a vaccine also raises questions about long-term impacts on immune regulation, potential autoimmunity and unintended synergistic effects that could compromise health rather than protect it.”

Keep reading

FDA Forces Moderna and Pfizer to Admit Covid “Vaccines” Cause Lasting Heart Damage in Young Males

For years, parents and medical professionals have sounded the alarm about the dangerous link between mRNA COVID-19 vaccines and heart inflammation in young males—only to be dismissed as “anti-vaxxers” or conspiracy theorists. Now, in a stunning reversal, the U.S. Food and Drug Administration (FDA) has ordered Pfizer and Moderna to strengthen their warning labels, finally admitting that these shots can cause long-lasting heart damage, particularly in adolescent boys and young men.

But this admission comes far too late—after millions of doses were administered under false pretenses, after countless young lives were altered by myocarditis, and after public health agencies actively suppressed the truth. The FDA’s belated action raises a critical question: How many more injuries could have been prevented if the government had prioritized transparency over blind vaccine promotion?

Key points:

  • The FDA has mandated that Pfizer and Moderna update their COVID-19 vaccine labels to include stronger warnings about myocarditis and pericarditis, particularly in males aged 16 to 25.
  • New data reveals that myocardial injury is often long-lasting, contradicting earlier CDC claims that heart inflammation “tends to resolve quickly.”
  • The highest incidence of myocarditis occurs in young males, with 38 cases per million doses—far higher than previously acknowledged.
  • Internal government emails show that health officials deliberately avoided warning the public about these risks, even after detecting safety signals in 2021.
  • The FDA’s action follows a Senate investigation exposing how federal agencies downplayed and hid vaccine injuries.

A long-overdue admission of harm

For years, independent researchers and medical professionals warned that mRNA vaccines posed a disproportionate risk to young, healthy individuals—especially males. Yet, public health agencies dismissed these concerns, insisting that the benefits outweighed the risks. Now, the FDA has been forced to acknowledge what health freedom fighters have said all along: These vaccines can cause serious, sometimes permanent, heart damage.

The updated labels must now state that myocardial injury is common among those who develop post-vaccination myocarditis, with data showing persistent damage five months after vaccination. This directly contradicts the CDC’s previous assurances that cases were “mild” and “resolved quickly.”

Why did it take so long? Internal documents obtained through FOIA requests reveal that as early as May 2021, the CDC and FDA considered issuing a public warning but ultimately chose silence over transparency.

The suppression of truth and the cost of deception

The Senate’s Permanent Subcommittee on Investigations recently released a damning report exposing how federal health agencies systematically concealed the myocarditis risk linked to COVID-19 vaccines. Internal emails reveal that officials engaged in a coordinated cover-up by refusing to update the V-safe reporting system to include cardiac symptoms, ensuring countless cases were never documented. Additionally, they blocked a planned Health Alert Network warning that would have alerted doctors and the public to the dangers, prioritizing public perception over transparency.

Keep reading

Moderna Shots vs. COVID Disease

A golden rule in vaccine manufacture is that you are supposed to create an inoculating substance which is, itself, less dangerous than the disease you aim to prevent. But new developments now allow more precise estimation than ever before regarding true harm from Moderna shots and true harm from COVID.

The 12-month death risk from COVID has a headline number which all rational persons understand to be overestimated. From a member of the COVID task force, a non-hands-on estimate of purposeful inflation of COVID death numbers was 25%.

But a hands-on (direct) estimate later on, from a doctor with actual experience at the bed-side during COVID (someone with boots on the ground, in the trenches), ended up tripling that first estimate which, to reiterate, had been produced from the White House bubble (without bed-side experience).

Keep reading

Trump Administration Considers Pulling Taxpayer Funds for Moderna’s Bird Flu Shot

The Trump administration is reportedly reconsidering the $590 million contract the Biden administration awarded to drug giant Moderna for an mRNA bird flu shot.

An initial report of the news at Bloomberg was critical of the move and referred to Moderna as being “known for its highly successful Covid-19 shot.”

“Robert F. Kennedy Jr., now President Donald Trump’s top health official, has been a vaccine skeptic and openly criticized Covid-19 shots,” the Bloomberg report stated. “In 2021, during the height of the pandemic, Kennedy called them ‘the deadliest vaccine ever made.’ According to the US National Institutes of Health, which now answers to Kennedy, Covid vaccines saved tens of millions of lives during the pandemic.”

The Wall Street Journal reported today that, in the wake of the news of the Department of Health and Human Services’ (HHS) review of the Biden move to fund its mRNA shot, Moderna shares fell 3%. Reuters reported the pharmaceutical company’s shares “fell 5.5% in after-market trading.”

Keep reading

Official Czech Republic record level data released Nov 2024 confirms Moderna has nearly 50% higher ACM than Pfizer

AFAIK, for the first time in human history a government has voluntarily released vaccine record-level data, the “gold standard” for vaccine safety analysis.

Woo hoo!

It shows the Moderna vaccine is unsafe. And based on other data, Pfizer is too.

The data and the analysis

Here it is: the Czech Republic record level data (1.3GB in size).

Since no epidemiologist in the world is analyzing this data (since it would be a career-limiting move), I guess it’s up to me to tell you what it says.

So I wrote about 150 lines of Python code to analyze it and you can download the summary spreadsheet here and take a look at what I found.

Basically, Moderna is a disaster. It increases All Cause Mortality (ACM) by around 50% relative to Pfizer, and that’s in non-COVID periods. So even if Pfizer is perfectly safe (it isn’t), Moderna should be immediately halted.

Keep reading

Moderna’s only real “FDA approved” product, an RSV mRNA injection is a failure

It goes without saying that RSV is a made up “virus” and there is no need to inject anyone with any alleged vaccines for it. This will only cause damage – scroll down to the part of this article where I discuss the FDA approved labeling for these shots. Sadly some people are still in a coma missing the lessons of the past 4 years of “safe and effective” so I hope that this information will help you with your efforts to wake those people up.

Despite being fully approved by the FDA in 2024, NOT as an EUA countermeasure (as best I can determine), the total revenue for this miracle of science is $10M so far. It’s refreshing to see that most people did not fall for the bullshit of RSV. I am willing to bet that even the $10M came from obligatory purchases by HHS to “stockpile” and assassinate an occasional Native American grandma, some prisoners, or other unfortunate subjects of the government healthcare services. In other words, no real uptake is happening.

Keep reading